The Stanford Center for Definitive and Curative Medicine, a joint initiative of the Stanford University School of Medicine, Stanford Health Care and Stanford Children’s Health, opened recently to provide the organizational and physical infrastructure to support investigator-in
You are here
Coverage of the latest news and updates from the field of stem cells.
Scientists may be able to minimize the failure rate of drugs for diseases linked to high-calorie diets, such as colon cancer and type 2 diabetes, if they test treatments using a pig model, according to an international team of researchers.
When blood flow is reduced or cut to tissues, cells are deprived of oxygen and nutrients, which can lead to cell death if blood flow isn’t efficiently restored. Stem cells are promising treatments, but they do not tend to stay at the site or survive long enough to heal the damage.
A $2.8 million grant from the National Institutes of Health (NIH) will help researchers at Rosalind Franklin University of Medicine and Science, Chicago, Illinois, study how to replace neurons lost through stroke, traumatic brain and spinal injury and brain diseases including Alzheimer's.
Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide without signals from growth factors.
Electric fields can be used to guide neural stem cells transplanted into the brain toward a specific location. The researchopens possibilities for effectively guiding stem cells to repair brain damage.
Investigators from Brigham and Women’s Hospital (BWH) and the Harvard Stem Cell Institute have a potential solution for how to kill tumor cells that have metastasized to the brain.
A groundbreaking advancement in materials from Northwestern University could potentially help patients requiring stem cell therapies for spinal cord injuries, stroke, Parkinson’s disease, Alzheimer’s disease, arthritic joints or any other condition requiring tissue regeneration, according to a ne
BioTech Holdings has announced clinical safety data on three patients suffering from critical limb ischemia treated with the company's Procell microbiome-optimized personalized stem cell product.
The Maryland Stem Cell Research Fund (MSCRF) has awarded TissueGene Inc., a Maryland-based regenerative medicine company, a clinical grant for Invossa™, a cell and gene therapy for degenerative arthritis.